Trial Information

Summary: Leg Pain and Diabetes

Do you have leg pain while exercising but it subsides at rest? You may be eligible to participate in a clinical trial.

Apex Research Institute is performing an 11-month research study evaluating the safety and effectiveness of an experimental medication on claudication (leg pain) in diabetic patients.

Qualified Participants must:

  • Be 40-80 years of age
  • Have intermittent claudication (leg pain during exercise, relief while at rest)
  • Have Type 2 Diabetes

All participants will receive, at no cost, study medication, treadmill testing, lab work, EKG, physical exams by board-certified physicians, specific vascular exams and Peripheral Neuropathy exams.

For more information on this and other clinical trials, please contact us at cdmcginty@hotmail.com.

Contact:

Cheryl McGinty, Site Recruitment Specialist
Apex Research Institute
999 N. Tustin Ave., #120
Santa Ana, CA 92705
Telephone: 714-542-3008 Ext. 306
Fax: 714-542-3617
Email:

Profile Page: Apex Research Institute, Santa Ana, CA

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:19 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA